Cyctek Re Ke Granule
Natural health product licensed in Canada
- Other names
- Re Ke Granule, Re Ke Granule Combination
- Licence holder
- CycTek Inc.
- NPN or DIN-HM
- 80064714
- Status
- Active licence
- Licence date
- 21 October 2015
- Revision date
- Not provided
- Form
- Granules
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Trichosanthes kirilowii Maxim.: L'absence de trichosanthine doit être prouvée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Coix lacryma-jobi var. ma-yuen Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 2,500 mg | 500 milligramme | Not calculated |
| Benincasa hispida Source : Exocarpede fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,250 mg | 250 milligramme | Not calculated |
| Trichosanthes kirilowii Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 2,000 mg | 400 milligramme | Not calculated |
| Pheretima aspergillum Source : En entier Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 milligramme | Not calculated |
| Morus alba Source : Écorce de racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,250 mg | 250 milligramme | Not calculated |
| Scutellaria baicalensis Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 milligramme | Not calculated |
| Fritillaria thunbergii Source : Bulbe Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 1,000 mg | 200 milligramme | Not calculated |
| Houttuynia cordata Source : Sommité Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 2,500 mg | 500 milligramme | Not calculated |
| Citrus aurantium Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 750 mg | 150 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, Stéarate de magnésium, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2,000 granule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Remedy/Product/Preparation based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80064714
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.